Clinical Trial Update: Assessing the Efficacy and Safety of Anti-HER2 Therapy in Nigerian Women With HER2+ Breast Cancer Before and After Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of anti-HER2 therapy in Nigerian women with HER2-positive breast cancer before and after surgery; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anti-HER2 Therapy

Snippet

Sponsor: University of Chicago | Conditions: Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, HER2-positive Breast Cancer | Phase 2 | Status: RECRUITING